Dermatology buyers and successors

Evaluate a prepared dermatology opportunity with the right evidence.

A useful first look is de-identified and business-only. It allows a prospective successor or buyer to assess revenue stream separation, pathology arrangements, device ownership, inventory controls, and surveillance workflows, before any introduction is considered.

Submit buyer criteria

Buyer proof packet

What a qualified buyer should see first.

The first useful buyer view is not a public listing. It is a de-identified operating packet that lets a buyer or physician successor decide whether the opportunity is worth owner-approved next disclosure.

01Anonymous fit screen

Broad geography, specialty, structure, transition goal, and fit hypothesis without name, address, records, or owner identity.

02Evidence gate

Clear separation between documented facts, owner-reported assumptions, missing documents, and items for counsel or CPA review.

03Disclosure ladder

Teaser, de-identified packet, qualified intro, then advisor handoff. The owner approves each step.

What a prepared opportunity should include

Operating economics

Trailing collections, expenses, replacement physician compensation, payer mix, and any adjustments identified for review.

Transferability

revenue stream separation, pathology arrangements, device ownership, inventory controls, and surveillance workflows. Information remains aggregate and excludes PHI.

Separate assets

Cosmetic products, device value, and pathology-related economics are treated separately from the core medical practice range.

Diligence questions worth asking early

01

Medical, Mohs, and cosmetic revenue split

02

Surveillance and pathology workflows

03

Device and inventory schedules

04

Referral and staffing continuity

Introductions remain practice-owner controlled. Doc2Doc does not provide patient-level data in early materials and does not present a planning estimate as a transaction commitment.